American Journal of Cardiology
Volume 100, Issue 9 , Pages 1404-1409 , 1 November 2007

Usefulness of Fasting Blood Glucose to Predict Vascular Outcomes Among Individuals Without Diabetes Mellitus (from the Northern Manhattan Study)

  • Kazuo Eguchi, MD

      Affiliations

    • Center for Behavioral Cardiovascular Health, Division of General Medicine, Columbia University Medical Center, New York, New York
    • Department of Cardiology, Columbia University College of Physicians and Surgeons, New York, New York
    • Corresponding Author InformationCorresponding author: Tel: 212-342-3674; fax: 212-342-3431.
    • ,
  • Bernadette Boden-Albala, DrPH

      Affiliations

    • Department of Neurology, Columbia University College of Physicians and Surgeons, New York, New York
    • Department of Sociomedical Science, Mailman School of Public Health, Columbia University, New York, New York
    • ,
  • Zhezhen Jin, PhD

      Affiliations

    • Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, New York
    • ,
  • Marco R. Di Tullio, MD

      Affiliations

    • Department of Cardiology, Columbia University College of Physicians and Surgeons, New York, New York
    • ,
  • Tatjana Rundek, MD, PhD

      Affiliations

    • Department of Neurology, Miller School of Medicine, University of Miami, Miami, Florida.
    • ,
  • Carlos J. Rodriguez, MD, MPH

      Affiliations

    • Department of Cardiology, Columbia University College of Physicians and Surgeons, New York, New York
    • ,
  • Shunichi Homma, MD

      Affiliations

    • Department of Cardiology, Columbia University College of Physicians and Surgeons, New York, New York
    • ,
  • Ralph L. Sacco, MD, MS

      Affiliations

    • Department of Neurology, Miller School of Medicine, University of Miami, Miami, Florida.
    • Dr. Sacco was supported by NINDS grant R01 29993.

Received 11 April 2007 ,Revised 5 June 2007 ,Accepted 5 June 2007.

Reference 

  1. Meigs JB, Nathan DM, D’Agostino RB, Wilson PW. Framingham Offspring Study. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care. 2002;25:1845–1850
  2. Selvin E, Coresh J, Golden SH, Brancati FL, Folsom AR, Steffes MW. Glycemic control and coronary heart disease risk in persons with and without diabetes: the Atherosclerosis Risk In Communities study. Arch Intern Med. 2005;165:1910–1916
  3. Smith NL, Barzilay JI, Shaffer D, Savage PJ, Heckbert SR, Kuller LH, et al. Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study. Arch Intern Med. 2002;162:209–216
  4. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events (A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years). Diabetes Care. 1999;22:233–240
  5. DECODE Study GroupEuropean Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 2001;161:397–405
  6. Novoa FJ, Boronat M, Saavedra P, Diaz-Cremades JM, Varillas VF, La Roche F, et al. Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde Study. Diabetes Care. 2005;28:2388–2393
  7. Blake DR, Meigs JB, Muller DC, Najjar SS, Andres R, Nathan DM. Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging. Diabetes. 2004;53:2095–2100
  8. Pankow JS, Kwan DK, Duncan BB, Schmidt MI, Couper DJ, Golden S, et al. Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the Atherosclerosis Risk in Communities Study. Diabetes Care. 2007;30:325–331
  9. Sacco RL, Elkind M, Boden-Albala B, Lin IF, Kargman DE, Hauser WA, et al. The protective effect of moderate alcohol consumption on ischemic stroke. JAMA. 1999;281:53–60
  10. Sacco RL, Anand K, Lee H-S, Boden-Albala B, Stabler S, Allen R, et al. Homocysteine and the risk of ischemic stroke in a triethnic cohort: the Northern Manhattan Study. Stroke. 2004;35:2263–2269
  11. Greene H, Richardson D, Barker A, Roden D, Capone R, Echt D, et al. Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the Cardiac Arrhythmia Pilot Study). Am J Cardiol. 1989;63:1–6
  12. Morris D, Kritchevsky S, Davis C. Serum carotenoids and coronary heart disease (The Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up Study). JAMA. 1994;272:1439–1441
  13. Tanne D, Koren-Morag N, Goldbourt U. Fasting plasma glucose and risk of incident ischemic stroke or transient ischemic attacks: a prospective cohort study. Stroke. 2004;35:2351–2355
  14. Milionis HJ, Rizos E, Goudevenos J, Seferiadis K, Mikhailidis DP, Elisaf MS. Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects. Stroke. 2005;36:1372–1376
  15. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care. 2005;28:385–390
  16. Scuteri A, Najjar SS, Morrell CH, Lakatta EG. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study. Diabetes Care. 2005;28:882–887
  17. Barrett-Connor E, Wingard DL. “Normal” blood glucose and coronary risk. BMJ. 2001;322:5–6
  18. Genuth S, Alberti K, Bennett P, Buse J, Defronzo R, Kahn R, et al Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160–3167
  19. Sacco RL, Boden-Albala B, Gan R, Chen X, Kargman DE, Shea S, et al. Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol. 1998;147:259–268
  20. Sacco RL, Boden-Albala B, Abel G, Lin IF, Elkind M, Hauser WA, et al. Race-ethnic disparities in the impact of stroke risk factors: the Northern Manhattan Stroke Study. Stroke. 2001;32:1725–1731
  21. Klatsky AL, Armstrong MA, Friedman GD. Racial differences in cerebrovascular disease hospitalizations. Stroke. 1991;22:299–304
  22. Ferris A, Robertson RM, Fabunmi R, Mosca L. American Heart Association and American Stroke Association national survey of stroke risk awareness among women. Circulation. 2005;111:1321–1326
  23. Diez Roux AV, Detrano R, Jackson S, Jacobs DR, Schreiner PJ, Shea S, et al. Acculturation and socioeconomic position as predictors of coronary calcification in a multiethnic sample. Circulation. 2005;112:1557–1565
  24. Sacco RL, Roberts JK, Boden-Albala B, Gu Q, Lin IF, Kargman DE, et al. Race-ethnicity and determinants of carotid atherosclerosis in a multiethnic population (The Northern Manhattan Stroke Study). Stroke. 1997;28:929–935
  25. Rundek T, White H, Boden-Albala B, Jin Z, Elkind MSV, Sacco RL. The metabolic syndrome and subclinical carotid atherosclerosis: the Northern Manhattan Study. J Cardiometabolic Syndrome. 2007;2:24–29
  26. Pollitt RA, Rose KM, Kaufman JS. Evaluating the evidence for models of life course socioeconomic factors and cardiovascular outcomes: a systematic review. BMC Public Health. 2005;5:7
  27. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004;141:421–431
  28. Robbins JM, Vaccarino V, Zhang H, Kasl SV. Socioeconomic status and type 2 diabetes in African American and non-Hispanic white women and men: evidence from the Third National Health and Nutrition Examination Survey. Am J Public Health. 2001;91:76

PII: S0002-9149(07)01459-2

doi: 10.1016/j.amjcard.2007.06.032

American Journal of Cardiology
Volume 100, Issue 9 , Pages 1404-1409 , 1 November 2007

Article Tools

* Image Usage & Resolution